-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
January 01, 2014 - techniques in patients for whom there is already a clear clinical and other noninvasive diagnostic
indication … techniques in
patients for whom there is already a clear clinical or other non-invasive diagnostic indication … 7 4.67
2
In patients in whom there is already a precatheterization indication
for stenting, what … In patients in whom there is already a clear clinical and other non-invasive diagnostic
indication suggesting … 7 4.67
2
In patients in whom there is already a precatheterization indication
for stenting, what
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - frequently early after its approval as monotherapy or with a
thiazolidinedione; neither is an FDA approved indication … The
indication for which exenatide was approved is “to improve glycemic control in patients with
type … very
early after approval; it was used as a monotherapy in 14% of the patients despite not having an
indication
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inconsistent efficacy, and little-to-no superiority
over competing off-label medications for this indication … Evzio also incorporates red and
green light-emitting diodes (LEDs), providing an alternate visual indication … Office of the Attorney General and the World Health Organization for this
indication.14,15 Naloxone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
November 01, 2023 - Reoperation rates were lower with
artificial disc replacement than ACDF; however, indication for reoperation
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
June 01, 2010 - important reasons for physicians to assign different treatments, selection bias is called
“confounding by indication … ” (Table 2, example 6).23 Confounding by indication is a common
problem in pharmacoepidemiological studies … from experts, the authors determined
that there were few (if any) RCTs on the use of heparin for this indication … Potential selection bias: confounding by indication
Carvedilol is an expensive, proprietary beta-blocker
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
June 01, 2010 - important reasons for physicians to assign different treatments, selection bias is called
“confounding by indication … ” (Table 2, example 6).23 Confounding by indication is a common
problem in pharmacoepidemiological studies … from experts, the authors determined
that there were few (if any) RCTs on the use of heparin for this indication … Potential selection bias: confounding by indication
Carvedilol is an expensive, proprietary beta-blocker
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - In August 2011,
NPS began submitting data for a new drug application to FDA for the same indication … patient education would be
necessary before this intervention would become widely diffused
for this indication … SBS.
21
In August 2011, NPS began submitting data for a new drug application to FDA for the same
indication … and completed the submission in December.
21
Teduglutide is not approved for any
indication by the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Conclusions for Each Indication in the BCBSA TEC Draft HSCT CER: Single HSCT
Versus Conventional Therapy … These gaps are crosscutting in
that they apply to more than one indication for HSCT. … Conclusions for each indication in the BCBSA TEC Draft HSCT CER: Single HSCT versus
conventional therapy … These diseases, or the specific indication within these diseases, all
are rare. … These
gaps are crosscutting in that they apply to more than one indication for HSCT.
-
effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
January 01, 2013 - Stratification on the propensity to receive a medication or strength of indication can identify clinically … Observational studies are susceptible to confounding by indication, ascertainment biases in exposure
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - inhibitor (ramipril) and ARB (telmisartan)
therapy are directly compared, there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication … inhibitor (ramipril) and ARB (telmisartan)
therapy are directly compared, there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Analysis
We classified hospitalizations where rFVIIa use was
reported into discrete, mutually exclusive indication … denominator of potential rFVIIa usage (i.e., total number
of patients eligible for use) by specific clinical
indication … evaluated the applicability
to real-world practice of the total body of evidence
within a given clinical indication … thereby
compromised by small study size, use of indirect
outcomes, and heterogeneity in dosage and indication … diminished by less acutely ill
patients and a mismatch between existing research and
real-world patterns of indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - Choice of
technique may depend on factors including the underlying indication for surgery … Regardless of indication, age may affect outcomes markedly in tonsillectomy;; younger children … Other comments suggested presenting results by
subgroup when possible (e.g., indication for … growth information,
and conditions such as Down Syndrome
• Operational definition of indication … important to describe will include age, BMI, variability in definition or
characterization of indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
April 01, 2016 - of resources and medications was not assessed.
»» There was potential for confounding by clinical indication
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - exemption approval for OCD, which marked the first FDA
approval of any DBS device for a psychiatric indication … drug and improve the efficacy ‘signal.’ ”
6
FDA has granted the agent fast
track status for this indication … device exemption, which was the first FDA approval of any kind for a DBS device for
a psychiatric indication … sometimes abused as a street drug (“Special K”), which may affect the regulatory pathway for this
indication … HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric indication
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - Food and Drug
Administration (FDA) approval of any DBS device for a psychiatric indication. … device exemption, which was the first FDA approval of any kind for a DBS device for a
psychiatric indication … These experts
were confident that, if available for use in this indication, ketamine has potential … clinically significant blood pressure increases.”
54
Although MAPS is conducting the studies for this indication … HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - Each of the target populations for
each reviewed indication is explicitly defined. … the data were primarily taken from industry-sponsored
clinical trials for one drug for one specific indication … comment,
but left the data in the report
since other atypicals have not
been FDA approved for this
indication … Similarly, our summary table of
benefits (Table 1) lists each
drug seperately for each
indication.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - for their
use; and second that, among patients with another indication,
those with CKD have a relatively … One could argue that if
patients are being treated for a non-CKD
indication (e.g. hypertension) and … are not
at treatment goal for that indication, no
additional information regarding CKD
status should … As stated above, if patients are being
treated for a non-CKD indication (e.g. … hypertension) and are not at treatment
goal for that indication, no additional
information regarding
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - I
couldn’t find an indication that outcome definitions were assessed
for rigidity or consistency (MI … for apixaban,
rivaroxaban and dabigatran because the question
clearly stated “In patients with an indication … We have kept prasugrel in the table since it was
studied for this indication. … We have kept prasugrel in the table since it was
studied for this indication. … We did not have a Key Question regarding the use
of oral anticoagulation (without an indication for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - States,
and are either FDA approved for VTE prophylaxis or are
used off label by clinicians for this indication … and
clopidogrel; as well as the anticoagulant warfarin, which
clinicians may use off label for this indication … The greatest
risk to their validity was confounding by indication in
that the sicker patients received … information that would need to
be captured would be filter-related information including
timing, indication … Future research using high-quality observational studies
that control for confounding by indication,
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - , one manufacturer is studying esketamine, the purified
(S)-enantiomer form of ketamine, for this indication … No scopolamine manufacturers are sponsoring registered clinical trials for this
indication. … FDA has granted
fast-track status to esketamine for this indication, and Janssen plans to also apply … behaviors, and delusions.67,76,77
Three registered clinical trials are ongoing for this off-label indication … Five experts, with clinical and research backgrounds, commented on off-label scopolamine for
this indication